The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
While I understand the sentiment, because of the size of the swings, SMT has been in an (albeit slow and choppy) upward trend since May last year. Some of my other funds have similar trends. Out of them, the best performing has been PCT. You might wish to look at that one. This s not a recommendation and as usual, do your own research.
RNS on 13 Nov 2023 said "The Phase 1C report is due to be delivered to the FCA, by no later than 28 February 2024. Further updates will be provided as appropriate." So I guess we will get notification that the submission has occurred, or that it has not and hopefully why the date was missed, at about the end of this month.
I asked Bing if PGMs are used in batteries and got the following reply:
Certainly! Platinum group metals (PGMs) are indeed utilized in lithium batteries, particularly in the pursuit of more efficient and advanced energy storage technologies. Here are some key points:
Lithium Batteries and PGMs:
Platinum group metals (which include elements like platinum and palladium) play a crucial role in enhancing battery performance.
These metals are used as catalysts within the battery system, specifically in the cathodes.
The goal is to improve rate capability (how quickly the battery can charge and discharge) and reduce the charge over potential.
PGMs contribute to the stability and efficiency of lithium batteries.
Recent Developments:
Platinum Group Metals (PTM) and its subsidiary Lion Battery Technologies have been at the forefront of this research.
Lion Battery Technologies was established by Anglo American Platinum (Amplats) and PTM to accelerate the development of next-generation battery technology using platinum and palladium.
The US Patent and Trademark Office has issued a second patent to Florida International University (FIU) related to the use of PGMs in lithium batteries.
The patent covers a preparation method using PGM catalysts in carbon materials for cathodes in various lithium batteries, including lithium-ion, lithium-air, and lithium-sulfur batteries1.
Potential Applications:
PGM-enhanced batteries have the potential to significantly improve the performance of battery electric vehicles (BEVs).
Additionally, PGMs find applications in other green technologies, such as cleaner emissions equipment for internal combustion engines and hydrogen fuel cell power generation in cars and trucks12.
In summary, PGMs are making strides in battery technology, aiming to create more efficient and sustainable energy storage solutions. 🚗⚡🔋
If this is correct, then regardless of the type of vehicle PGMs will be required. How much of each metal there would be in each type of vehicle is not clear from the above, but electric vehicles contain large numbers of cells so intuitively one might expect them to need more than trace amounts. In addition, there are various battery storage schemes being developed to support electricity generation projects. This suggests the future might be brighter than the market is currently suggesting.
Successive governments have promised to cut red tape for as long as I can remember but they have all failed to deliver. While an incoming administration might surprise us all by doing what it promises, history makes this improbable as they all seem to get bogged down in the minutiae that affects a small number of cases while missing the needs of the vast majority.
Your summary of recent market reactions is pretty accurate, Oogleflugal. If anyone doubts it just look at Bango this week where, although their result were disappointing, they hardly warranted a 48% drop on release. All one can hope is that ultimately things will settle down and sound companies that have a good track record, like Avingtrans, will again trade at fair value. Although interest rate reductions may help, this is, unfortunately, unlikely to occur until after the US elections and it may not happen until the situations in Ukraine and the Middle East are resolved. By then, we may be looking at developing situations in the Baltics and Taiwan so I feel that considerable patience may be needed.
Remember this, which was posted recently? https://bango.com/if-2023-was-the-year-super-bundling-took-off-2024-will-go-stratospheric/ It seems somewhat incompatible with the market reaction. Indeed, such a rapid share price collapse almost suggests that there is something else lurking in the background, or am I paranoid?
Over the last week or so there have been some impressive percentage daily changes recorded in the share price on this page, yet the actual price has stayed flat or declined. Is anyone else having difficulty understanding the data?
Pedrobull. While it is true that Israel is a "nuclear state", if they were to resort to striking Iran with nuclear weapons as your post seems to imply, I suggest that we would have more to worry about than the price of BATM shares.
I suppose the question for potential buyers will be what will it cost me for each test (and how many will I need per patient) versus how much will I save, on average, on the treatment of that patient? In short, how much will I save if I use the tests and how much inconvenience will be incurred or saved? I do not know the answer to this but the saving in time and money will need to be relatively significant for users to change procedures and adopt the testing. The lack of sales suggests either that the benefits are considered to be marginal, or that the sales force is not getting the significant savings message across to the potential users. Does anyone know which is the case?
Unfortunately, yes. Unfortunately in the sense that there are often large movements in share prices in one direction or the other just before a market announcement is made. Call me an old cynic if you like but I am pretty certain that the movements are based on leaks and not just dumb luck! Thankfully in the case of Jarvis, on this occasion, one might expect the news that appears as if it will be announced imminently will be favourable. I am tempted to add "about time".
ÂŁ117m per annum would be nice, Pedrobull, but please note the words "up to" in the statement "Trident owns an off take for 100% of the gold produced up to 58.5koz per year .....". This suggests that the final figure may be, or even may likely be, less, or even substantially less, than this upper limit. Time will tell of course but I will keep my fingers crossed.
Comment in the IC this week.
“Although Ramsdens continues to outperform analysts’ earnings expectations, prompting another round of upgrades post results last summer, the shares are only priced on a forward PE ratio of nine and offer an attractive prospective dividend yield of 4.9 per cent. A price-to-book value of 1.3 times is modest for a cash-rich company generating a post-tax return on equity of 17 per cent and one that is performing well during a cost-of-living crisis. Liberum’s target of 290p is more than a third higher than Ramsden’s current share price.”